BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26637331)

  • 1. Severe gastritis decreases success rate of Helicobacter pylori eradication.
    Kalkan IH; Sapmaz F; Güliter S; Atasoy P
    Wien Klin Wochenschr; 2016 May; 128(9-10):329-34. PubMed ID: 26637331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
    Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
    Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
    Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
    Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
    Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
    Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
    Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
    World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients.
    Zerbib F; Lenk C; Sawan B; Cayla R; Broutet N; Carles B; de Mascarel A; Mégraud F; Lamouliatte H
    Eur J Gastroenterol Hepatol; 2000 Jul; 12(7):719-25. PubMed ID: 10929896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The corpus-predominant gastritis index may serve as an early marker of Helicobacter pylori-infected patients at risk of gastric cancer.
    Tsai YC; Hsiao WH; Yang HB; Cheng HC; Chang WL; Lu CC; Sheu BS
    Aliment Pharmacol Ther; 2013 May; 37(10):969-78. PubMed ID: 23550594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
    Na YS; Kim SG; Cho SJ
    Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
    Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
    World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication rate and histological changes after Helicobacter pylori eradication treatment in gastric cancer patients following subtotal gastrectomy.
    Hwang JJ; Lee DH; Kang KK; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(13):3936-43. PubMed ID: 25852279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
    Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
    Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
    Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
    Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
    Kang JM; Kim N; Shin CM; Lee HS; Lee DH; Jung HC; Song IS
    Helicobacter; 2012 Apr; 17(2):86-95. PubMed ID: 22404438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
    Nasser SC; Slim M; Nassif JG; Nasser SM
    World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
    Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
    Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development.
    Hara D; Okamura T; Iwaya Y; Nagaya T; Ota H; Umemura T
    Helicobacter; 2022 Dec; 27(6):e12934. PubMed ID: 36263778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication].
    Lee Y; Jeon YC; Koo TY; Cho HS; Byun TJ; Kim TY; Lee HL; Eun CS; Lee OY; Han DS; Sohn JH; Yoon BC
    Korean J Gastroenterol; 2007 Nov; 50(5):299-305. PubMed ID: 18159161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer.
    Kodama M; Murakami K; Okimoto T; Abe H; Sato R; Ogawa R; Mizukami K; Shiota S; Nakagawa Y; Soma W; Arita T; Fujioka T
    Scand J Gastroenterol; 2013 Nov; 48(11):1249-56. PubMed ID: 24079881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
    Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
    Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.